Activation and priming of neutrophil nicotinamide adenine dinucleotide phosphate oxidase and phospholipase A₂ are dissociated by inhibitors of the kinases p42^ERK2 and p38^SAPK and by methyl arachidonyl fluorophosphonate, the dual inhibitor of cytosolic and calcium-independent phospholipase A₂MOLLAPOUR, Elahe; LINCH, David C; ROBERTS, Pamela J et al.Blood. 2001, Vol 97, Num 8, pp 2469-2477, issn 0006-4971Article

Vaccine strategies in non-Hodgkin's lymphomasBRISSINCK, J; RUSSELL, S. J.Baillière's clinical haematology. 1996, Vol 9, Num 4, pp 799-817, issn 0950-3536Article

Anti-sense and gene therapy approaches to the treatment of lymphomasDEVEREUX, S; COTTER, F. E.Baillière's clinical haematology. 1996, Vol 9, Num 4, pp 819-834, issn 0950-3536Article

Most acute myeloid leukaemia patients with intermediate mutant FLT3/ITD levels do not have detectable bi-allelic disease, indicating that heterozygous disease alone is associated with an adverse outcomeGREEN, Claire; LINCH, David C; GALE, Rosemary E et al.British journal of haematology. 2008, Vol 142, Num 3, pp 423-426, issn 0007-1048, 4 p.Article

Treatment of the elderly patient with diffuse large B cell lymphomaFIELDS, Paul A; LINCH, David C.British journal of haematology. 2012, Vol 157, Num 2, pp 159-170, issn 0007-1048, 12 p.Article

Classification of non-Hodgkin's lymphomasNORTON, A. J.Baillière's clinical haematology. 1996, Vol 9, Num 4, pp 641-652, issn 0950-3536Article

Gut lymphomasZUCCA, E; CAVALLI, F.Baillière's clinical haematology. 1996, Vol 9, Num 4, pp 727-741, issn 0950-3536Article

The role of allogeneic transplantation in non-Hodgkin's lymphomaPEGGS, Karl S; MACKINNON, Stephen; LINCH, David C et al.British journal of haematology. 2005, Vol 128, Num 2, pp 153-168, issn 0007-1048, 16 p.Article

Practical role of molecular diagnostics in non-Hodgkin's lymphomasMAUVIEUX, L; MACINTYRE, E. A.Baillière's clinical haematology. 1996, Vol 9, Num 4, pp 653-667, issn 0950-3536Article

Management of histologically indolent non-Hodgkin's lymphomasSOLAL-CELIGNY, P.Baillière's clinical haematology. 1996, Vol 9, Num 4, pp 669-687, issn 0950-3536Article

Management of the histologically aggressive non-Hodgkin's lymphomas in adultsLINCH, D. C.Baillière's clinical haematology. 1996, Vol 9, Num 4, pp 689-706, issn 0950-3536Article

The production of JAK2 wild-type platelets is not downregulated in patients with JAK2 V617F mutant-positive essential thrombocythaemiaLAMBERT, Jonathan R; GALE, Rosemary E; LINCH, David C et al.British journal of haematology. 2009, Vol 145, Num 1, pp 128-130, issn 0007-1048, 3 p.Article

Influence of cell cycling and cell division on transendothelial migration of CD34⁺ cellsYONG, Kwee L; FAHEY, Anne; PIZZEY, Arnold et al.British journal of haematology. 2002, Vol 119, Num 2, pp 500-509, issn 0007-1048, 10 p.Article

Gö6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cellsGRANDAGE, Victoria L; EVERINGTON, Tamara; LINCH, David C et al.British journal of haematology. 2006, Vol 135, Num 3, pp 303-316, issn 0007-1048, 14 p.Article

Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitorsSOMERVAILLE, Tim C. P; LINCH, David C; KHWAJA, Asim et al.British journal of haematology. 2003, Vol 120, Num 5, pp 876-886, issn 0007-1048, 11 p.Article

Management of cutaneous lymphomaRUSSELL-JONES, R; SPITTLE, M. F.Baillière's clinical haematology. 1996, Vol 9, Num 4, pp 743-767, issn 0950-3536Article

Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cellsJAKUPOVIC, Ira; GRANDAGE, Victoria L; LINCH, David C et al.Blood. 2004, Vol 103, Num 8, pp 3230-3232, issn 0006-4971, 3 p.Article

A review of gene therapy for haematological disordersNATHWANI, Amit C; DANIDOFF, Andrew M; LINCH, David C et al.British journal of haematology. 2005, Vol 128, Num 1, pp 3-17, issn 0007-1048, 15 p.Article

FLT3 mutations and leukaemiaPANACIOTIS; KOTTARIDIS, D; GALE, Rosemary E et al.British journal of haematology. 2003, Vol 122, Num 4, pp 523-538, issn 0007-1048, 16 p.Article

Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and BaxSOMERVAILLE, Tim C. P; LINCH, David C; KHWAJA, Asim et al.Blood. 2001, Vol 98, Num 5, pp 1374-1381, issn 0006-4971Article

Constitutive activation of the Wnt/β-catenin signalling pathway in acute myeloid leukaemiaSIMON, Maria; GRANDAGE, Victoria L; LINCH, David C et al.Oncogene (Basingstoke). 2005, Vol 24, Num 14, pp 2410-2420, issn 0950-9232, 11 p.Article

Management of paediatric lymphomaPHILIP, T; BERGERON, C; FRAPPAZ, D et al.Baillière's clinical haematology. 1996, Vol 9, Num 4, pp 769-797, issn 0950-3536Article

Treatment for lymph node tuberculosisSELLAR, Rob S; CORBETT, E. L; D'SA, Shirley et al.BMJ. British medical journal (International ed.). 2010, Vol 340, Num 7747, pp 653-655, issn 0959-8146, 3 p.Article

Page / 4